^

Augmenting TMS response in MDD: We know DLPFC-TMS works, and for non-responders that OFC-TMS adds some 20 % remissions, so what if we combine these two protocols? Large sample shows no advantage. Maybe it is about specificity of TMS? Congrats @AmouriePrentice and @NikitaVinne with this work, and great collaboration with @JonathanDownar brainstimjrnl.com/article/S1…

Exciting early results from ⁦@JonathanDownar⁩ on accelerated dorsomedial TMS for anxiety.

Save-the-date: Brainclinics TMS Certification Course and Masterclass May 21-23, 2024 with great speakers: Nolan Williams, Dirk de Ridder, Kristin Raj, Jonathan Downar, Nikita van der Vinne and more... Sign-up here: brainclinics.com/tms-certifi… @NolanRyWilliams @KristinRajMD @JonathanDownar @Brai3nClinic @NikitaVinne @ClinicalTMS @AmouriePrentice @Hersenstim

Effectiveness of OFC-TMS in patients unresponsive to DLPFC TMS, just published in @brainstimj . Not all depressed patients respond to standard DLPFC TMS, and given their resistance to treatments alternatives are needed. Here we show in two independent samples from @neurocaregroup in Nijmegen and New York that patients unresponsive to DLPFC TMS can still remit to OFC TMS (Remission: 24-31%). Congrats @AmouriePrentice as first author, and @NikitaVinne @YlkaKolken @JonathanDownar @Sack_BSClab Christina, Joris, Richard, Iris & Vera. authors.elsevier.com/sd/arti…

Glad to see this published: rACC theta has often been implicated as a predictor for antidepressant response. Here we show that rACC theta scales with level of treatment resistance from first-line treatments to TRD treatments such as TMS and ECT. Next question to solve is: Cause or effect, i.e. is high rACC theta a biomarker for resistance to first line treatments, or does repeated exposure to antidepressant treatments cause this increased rACC theta? Congrats @AmouriePrentice with first-first author publicaton! Also thanks to great team of collaborators and sharing data: @ARitaBarreiros, @NikitaVinne, Sven Stuiver, @hanvdij, Jeroen van Waarde, @DrMKorgaonkar, @AlexanderSack72 karger.com/nps/article/doi/1…

In a letter to the editor Amourie Prentice et al. demonstrate efficacy of 1Hz rTMS directed to the Orbitofrontal cortex in depressed participants that initially did not respond to standard DLPFC stimulation brainstimjrnl.com/article/S1…

Still few places left for the Brainclinics TMS Certification course and TMS Masterclass in April. Join us for an exciting once-yearly event with great line-up of speakers: @shansiddiqi @JonathanDownar Odile van den Heuvel @Martijn_Figee_ @NikitaVinne brainclinics.com/tms-certifi…

Come see @NikitaVinne and @AmouriePrentice poster next week at #BrainStimConf 1-Hz TMS over right OFC as a new TMS-target for depressed patients unresponsive to DLPFC TMS results in 24-31% remission in two independent samples.

ESBS Webinar: EU Reclassification of TMS and tDCS to Class III - brain-stimulation.eu website. Join us this Friday! ⁦@CBaeken⁩ ⁦@neuromodec⁩ ⁦@brainstimj⁩ ⁦⁦@flowneurosci⁩ brain-stimulation.eu/manifes…

Save-the-date, April 12-14 2023: TMS Masterclass & Certification course with great line-up of speakers: @shansiddiqi Odile A. van den Heuvel, @JonathanDownar @Martijn_Figee and many more... Location: Nijmegen, the Netherlands

Mooie bijdrage van onze PhD Hannah Meijs over haar onderzoek naar EEG-netwerken geïdentificeerd aan de hand van genetische risico scores bij depressie en voorspelt response op antidepressiva, psychotherapie en rTMS bij mannen nedkad.nl/nieuws/eeg-compone… @angstdepressie @JurjenLuykx

The 5th International Brain Stimulation Conference by @brainstimj will be 18–22 February 2023 in Lisbon, Portugal. #BrainStimConf Abstract and Symposium submission deadline is Sep 9, 2022: elsevier.com/events/conferen…

Looking for a research assistant. Send your CV to BWHCBCTAssistants@partners.org. Only apply if you'd like to be happy and successful. Position is not great for people who don't want those things. Also nice if you either (a) write code, or (b) want to grow into a lab manager.

Just published: A polygenic-informed approach to a predictive EEG signature empowers antidepressant treatment prediction. Great new paper, congrats to Hannah Meijs. @AcademicEEG @ClinicalNeuroph @JurjenLuykx @AmouriePrentice authors.elsevier.com/sd/arti…

Thoroughly enjoyed participating in the @Brainclinics #ResearchDay last week! Learned so many new things, and was inspired by all the efforts of the people involved to translate tough #BrainStimulation science to direct clinical applications.

Sign-up now for the 5th European Brain Stimulation, great program! Speakers include Andrea Antal @NolanRyWilliams Albino Oliveira-Maia @CBaeken @ZhiDeDeng @DebbyKlooster @shansiddiqi Jonathan Downar @MartinTik1 @hanvdij and many others.... brain-stimulation2022.com/

New study-protocol published, by Iris Dalhuisen et al. rTMS combined with CBT as a next step in antidepressant non-responders: a study protocol for a randomized comparison with current antidepressant treatment approaches bmcpsychiatry.biomedcentral.…

Exclusive preview of @Martijn_Arns and his team's research into Neuro-Cardiac-Guided-TMS 2.0. - a method to help rTMS practitioners better localize the coil for the treatment of depression. Full interview with Dr. Trevor Brown in our article. info.neurocaregroup.com/news…